Terms: = Leukemia AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL
24 results:
1. The validation and clinical significance of LPCAT1 down-regulation in acute myeloid leukemia.
Chen Q; Xu Z; Lin J; Deng Z; Qian J; Qian W
Mol Biol Rep; 2023 Jun; 50(6):4955-4963. PubMed ID: 37079124
[TBL] [Abstract] [Full Text] [Related]
2. Timing of Central Venous Line Insertion During Induction in Children With Acute Lymphoblastic leukemia.
Ataseven E; Yilmaz Ş; Tüfekçi Ö; Ören H
J Pediatr Hematol Oncol; 2023 Jan; 45(1):25-28. PubMed ID: 36598960
[TBL] [Abstract] [Full Text] [Related]
3. ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia.
Lipreri da Silva JC; Saldanha-Araujo F; de Melo RCB; Vicari HP; Silva-Carvalho AE; Rego EM; Buccheri V; Machado-Neto JA
Life Sci; 2022 Dec; 311(Pt B):121146. PubMed ID: 36336127
[TBL] [Abstract] [Full Text] [Related]
4. Clinical decision rule for obtaining peripheral blood cultures in febrile oncology patients.
Gorfinkel L; Hansen CE; Teng W; Shabanova V; Prozora S; Rodwin R; Qadri U; Manghi T; Emerson B; Riera A
Pediatr Blood Cancer; 2022 May; 69(5):e29519. PubMed ID: 34939321
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.
Lipreri da Silva JC; Coelho-Silva JL; Lima K; Vicari HP; Lazarini M; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2021 Oct; 44(5):1105-1117. PubMed ID: 34196912
[TBL] [Abstract] [Full Text] [Related]
6. The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 May; 19(1):228. PubMed ID: 34051812
[TBL] [Abstract] [Full Text] [Related]
7. Low Risk of Central Line-associated Bloodstream Infections in Pediatric Hematology/Oncology Patients.
Kristinsdottir I; Haraldsson A; Gudlaugsson O; Thors V
Pediatr Infect Dis J; 2021 Sep; 40(9):827-831. PubMed ID: 33990520
[TBL] [Abstract] [Full Text] [Related]
8. Noble Metal Coated Central Venous Catheters Are Not Superior To Uncoated Catheters In Preventing Infectious And Non-Infectious Complications In Immunocompromised Patients.
Iftikhar R; Chaudhry QUN; Satti TM; Mahmood SK; Satti HS; Ghafoor T; Khan MA
J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S647-S651. PubMed ID: 30838824
[TBL] [Abstract] [Full Text] [Related]
9. Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols.
Bhatt MD; Parmar N; Fowler JA; Chan AKC; Athale UH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27483. PubMed ID: 30362248
[TBL] [Abstract] [Full Text] [Related]
10. Thrombosis in pediatric patients with leukemia.
Levy-Mendelovich S; Barg AA; Kenet G
Thromb Res; 2018 Apr; 164 Suppl 1():S94-S97. PubMed ID: 29703491
[TBL] [Abstract] [Full Text] [Related]
11. A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.
Roininen S; Laine O; Kauppila M; Vesanen M; Rämet M; Sinisalo M; Jantunen E; Säily M; Räty R; Elonen E; Wartiovaara-Kautto U
Cancer Med; 2017 Jun; 6(6):1275-1285. PubMed ID: 28503810
[TBL] [Abstract] [Full Text] [Related]
12. Epidemiology of venous thrombosis in children with cancer.
Piovesan D; Attard C; Monagle P; Ignjatovic V
Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
[TBL] [Abstract] [Full Text] [Related]
13. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
Del Giudice I; Messina M; Chiaretti S; Santangelo S; Tavolaro S; De Propris MS; Nanni M; Pescarmona E; Mancini F; Pulsoni A; Martelli M; Di Rocco A; Finolezzi E; Paoloni F; Mauro FR; Cuneo A; Guarini A; Foà R
Br J Haematol; 2012 Mar; 156(5):601-11. PubMed ID: 22150124
[TBL] [Abstract] [Full Text] [Related]
14. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract] [Full Text] [Related]
15. Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells.
Queiroz AF; Silva RA; Moura RM; Dreyfuss JL; Paredes-Gamero EJ; Souza AC; Tersariol IL; Santos EA; Nader HB; Justo GZ; de Sales MP
Cancer Chemother Pharmacol; 2009 May; 63(6):1023-33. PubMed ID: 18781302
[TBL] [Abstract] [Full Text] [Related]
16. Thromboembolic complications in pediatric hematologic malignancies.
Athale UH; Chan AK
Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
[TBL] [Abstract] [Full Text] [Related]
17. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract] [Full Text] [Related]
18. Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles.
Gargiulo AR; Fichorova RN; Politch JA; Hill JA; Anderson DJ
Fertil Steril; 2004 Oct; 82 Suppl 3():1226-34. PubMed ID: 15474100
[TBL] [Abstract] [Full Text] [Related]
19. Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy.
Athale UH; Chan AK
Thromb Res; 2003; 111(4-5):199-212. PubMed ID: 14693164
[TBL] [Abstract] [Full Text] [Related]
20. Central venous line-related thrombosis in children: association with central venous line location and insertion technique.
Male C; Chait P; Andrew M; Hanna K; Julian J; Mitchell L;
Blood; 2003 Jun; 101(11):4273-8. PubMed ID: 12560228
[TBL] [Abstract] [Full Text] [Related]
[Next]
